About
Dapagliflozin and Metformin is a combination medication specifically formulated for the comprehensive management of type 2 diabetes mellitus in adults. Dapagliflozin, an SGLT2 inhibitor, works by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and a subsequent reduction in blood sugar levels. This mechanism also contributes to its beneficial effects on cardiovascular outcomes and kidney function, offering protection beyond glycemic control.
Metformin, a biguanide, complements this action by primarily decreasing glucose production in the liver, reducing glucose absorption from the intestines, and improving the body's sensitivity to insulin. This dual mechanism of action provides a robust approach to glycemic control, effectively lowering HbA1c and improving overall metabolic health. The combination is particularly valuable for patients who require more intensive blood sugar management or who can benefit from the additional cardiovascular and renal protective properties.
Uses
- Management of type 2 diabetes mellitus.
- To improve glycemic control in adults.
- When diet and exercise alone are insufficient.
- To reduce the risk of cardiovascular events in certain patients.
Directions For Use
Take orally twice daily with meals, or as directed by your physician.
Benefits
- Significant reduction in blood glucose levels.
- Improved insulin sensitivity.
- Supports modest weight loss.
- Offers cardiovascular protection.
- Provides renal benefits.
- Lowers HbA1c effectively.
Side Effects
- Nausea and vomiting.
- Diarrhea and abdominal pain.
- Genital yeast infections.
- Urinary tract infections.
- Increased urination.
- Metallic taste in mouth.
- Dizziness or lightheadedness.
- Hypoglycemia (especially with other agents).
- Lactic acidosis (rare but serious).
- Dehydration.
- Vitamin B12 deficiency.
Safety Measures
- Alcohol - Avoid excessive alcohol intake as it can increase the risk of lactic acidosis and hypoglycemia.
- Pregnancy - Generally not recommended, especially in the second and third trimesters due to potential fetal renal effects. Consult a doctor.
- Breastfeeding - Not recommended as components may pass into breast milk, potentially affecting the infant.
- Liver - Use with caution in patients with liver impairment due; increased risk of lactic acidosis with metformin.
- Kidney - Contraindicated in severe renal impairment due to increased risk of lactic acidosis and reduced efficacy of dapagliflozin.
- Lung - Generally safe for use in patients with lung conditions; no specific lung contraindications.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!